Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Debt Ratio (2016 - 2026)

Cytosorbents filings provide 9 years of Debt Ratio readings, the most recent being 0.38 for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 27.68% to 0.38 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.38, a 27.68% increase, with the full-year FY2025 number at 0.38, up 27.68% from a year prior.
  • Debt Ratio hit 0.38 in Q4 2025 for Cytosorbents, up from 0.32 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.38 in Q4 2025 to a low of 0.08 in Q4 2022.
  • Median Debt Ratio over the past 4 years was 0.27 (2024), compared with a mean of 0.22.
  • Biggest five-year swings in Debt Ratio: skyrocketed 210.26% in 2024 and later grew 10.25% in 2025.
  • Cytosorbents' Debt Ratio stood at 0.08 in 2022, then grew by 20.43% to 0.1 in 2023, then skyrocketed by 210.26% to 0.3 in 2024, then grew by 27.68% to 0.38 in 2025.
  • The last three reported values for Debt Ratio were 0.38 (Q4 2025), 0.32 (Q3 2025), and 0.3 (Q2 2025) per Business Quant data.